The global Anti-biofilm Wound Dressing market size was reached at USD 656.57 million in 2020 and is projected to surpass US$ 2.03 Tillion by 2030, expanding growth at a CAGR of 14.2% from 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38542
Growth Factors
The rising incidence of Hospital Acquired Infections (HAIs), the growing prevalence of chronic diseases, and the increasing number of burn cases are the key driving factors for the market.
Increasing the prevalence of chronic diseases across the globe is anticipated to drive the market. For instance, as per the International Diabetes Federation, the global prevalence of diabetes is expected to increase from 766.0 million in 2011 to 602.0 million by 2030. Increasing cases of accidents and trauma such as burns are expected to contribute to market growth. Traumatic events are most common in low and middle-income countries in comparison to high-income countries. Around 50.00% of people globally are exposed to fire-related traumas.
Report Coverage
| Report Scope | Details |
| Market Size | USD 2.03 Trillion by 2030 |
| Growth Rate | CAGR of 14.2% From 2021 to 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Mode of Mechanism, Application |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | ConvaTec; Smith & Nephew PLC; Urgo Medical; Coloplast; 3M |
Report Highlights
The acute wounds segment held the largest share of over 65.0% in 2020 owing to the rising cases of burns and trauma and the increasing number of surgeries across the globe. An acute wound is an injury to the skin that occurs unexpectedly and includes incisions, abrasions, burns, scratches, and puncture wounds. It heals at a normal rate according to the regular wound healing process.
The chronic wounds segment is anticipated to witness the fastest growth over the forecast period owing to the increasing cases of chronic diseases, especially diabetes, across the globe. Chronic or non-healing wounds occur when there is no significant healing of an injury for about 4 weeks.
The chemical mode of mechanism segment held the largest share of over 50.0% in 2020 and is anticipated to witness the fastest growth over the forecast period owing to the rising prevalence of chronic wounds and the increasing number of surgeries across the globe.
The presence of several players offering anti-biofilm wound dressing products with iodine and ionic silver is the major factor promoting the segment growth. In addition, researchers are taking initiatives to introduce advanced anti-biofilm wound dressing products in the market for better treatment of chronic and acute wounds.
North America dominated the market with a share of more than 50.0% in 2020 and is expected to witness considerable growth over the forecast period. The increasing incidence of sports injuries, rising number of road accidents, and the presence of several key players in the region are some of the factors expected to drive the market.
Key Players
- ConvaTec
- Smith & Nephew PLC
- Urgo Medical
- Coloplast
- 3M
Market Segmentation
- Mode of Mechanism
- Physical
- Manual Debridement
- Pulse Electrical Field
- Ultrasound Debridement
- Chemical
- Ionic Silver
- Iodine
- EDTA
- Others
- Biological
- Dispersin B
- Lactoferrin
- Bacteriophage
- Others
- Physical
- Application
- Chronic Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Others
- Acute Wounds
- Surgical & Traumatic Wounds
- Burn Wounds
- Chronic Wounds
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
- Saudi Arabia
- North America
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38542
Reasons to Purchase this Report:– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Anti-biofilm Wound Dressing Market, By Mode of Mechanism
7.1. Anti-biofilm Wound Dressing Market, by Mode of Mechanism, 2021-2030
7.1.1. Physical
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Chemical
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Biological
7.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Anti-biofilm Wound Dressing Market, By Application
8.1. Anti-biofilm Wound Dressing Market, by Application, 2021-2030
8.1.1. Chronic Wounds
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Acute Wounds
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Anti-biofilm Wound Dressing Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.1.2. Market Revenue and Forecast, by Application (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.1.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.2.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.2.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.3.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.4.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.5.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Mode of Mechanism (2017-2030)
9.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
Chapter 10. Company Profiles
10.1. ConvaTec
10.1.1. Company Overview
10.1.2. Mode of Mechanism Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Smith & Nephew PLC
10.2.1. Company Overview
10.2.2. Mode of Mechanism Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Urgo Medical
10.3.1. Company Overview
10.3.2. Mode of Mechanism Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Coloplast
10.4.1. Company Overview
10.4.2. Mode of Mechanism Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. 3M
10.5.1. Company Overview
10.5.2. Mode of Mechanism Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38542
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
